Glenmark Pharma down over 4%; market-cap erodes by Rs 1,015 crore

Shares of  Glenmark Pharmaceuticals  today lost 4.51% after the  Delhi high court  barred it from making, marketing or selling its anti-diabetes medicines. On March 20, the court barred Glenmar…